11-2572970-C-T
Variant summary
Our verdict is Pathogenic. Variant got 16 ACMG points: 16P and 0B. PM1PM5PP3_StrongPP5_Very_Strong
The NM_000218.3(KCNQ1):c.905C>T(p.Ala302Val) variant causes a missense change. The variant allele was found at a frequency of 0.00000868 in 1,613,434 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A302E) has been classified as Pathogenic.
Frequency
Consequence
NM_000218.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 16 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
KCNQ1 | NM_000218.3 | c.905C>T | p.Ala302Val | missense_variant | 6/16 | ENST00000155840.12 | NP_000209.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
KCNQ1 | ENST00000155840.12 | c.905C>T | p.Ala302Val | missense_variant | 6/16 | 1 | NM_000218.3 | ENSP00000155840 | P1 | |
KCNQ1 | ENST00000335475.6 | c.524C>T | p.Ala175Val | missense_variant | 6/16 | 1 | ENSP00000334497 | |||
KCNQ1 | ENST00000496887.7 | c.644C>T | p.Ala215Val | missense_variant | 7/16 | 5 | ENSP00000434560 | |||
KCNQ1 | ENST00000646564.2 | c.478-10465C>T | intron_variant | ENSP00000495806 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152198Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.00000401 AC: 1AN: 249650Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 135344
GnomAD4 exome AF: 0.00000890 AC: 13AN: 1461236Hom.: 0 Cov.: 32 AF XY: 0.00000825 AC XY: 6AN XY: 726906
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152198Hom.: 0 Cov.: 33 AF XY: 0.0000134 AC XY: 1AN XY: 74350
ClinVar
Submissions by phenotype
not provided Pathogenic:4
Likely pathogenic, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Aug 01, 2024 | KCNQ1: PM1, PM5, PS4:Moderate, PM2:Supporting, PS3:Supporting - |
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Jan 05, 2024 | Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 29876285, 34505893, 15466642, 15840476, 19716085, 19490272, 19808498, 27409154, 22581653, 31447099, RidaM2023[Preprint], 32431610, 33332384, 35486589, 27917693, 24144883, 25786344, 17905336) - |
Likely pathogenic, no assertion criteria provided | clinical testing | Clinical Genetics, Academic Medical Center | - | - - |
Likely pathogenic, no assertion criteria provided | clinical testing | Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+ | - | - - |
Long QT syndrome Pathogenic:3Other:1
Pathogenic, no assertion criteria provided | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Apr 03, 2015 | - - |
not provided, no classification provided | phenotyping only | GenomeConnect - Brain Gene Registry | - | Variant classified as not provided and reported on 05-21-2020 by GeneDx. Assertions are reported exactly as they appear on the patient provided laboratory report. GenomeConnect does not attempt to reinterpret the variant. The IDDRC-CTSA National Brain Gene Registry (BGR) is a study funded by the U.S. National Center for Advancing Translational Sciences (NCATS) and includes 13 Intellectual and Developmental Disability Research Center (IDDRC) institutions. The study is led by Principal Investigator Dr. Philip Payne from Washington University. The BGR is a data commons of gene variants paired with subject clinical information. This database helps scientists learn more about genetic changes and their impact on the brain and behavior. Participation in the Brain Gene Registry requires participation in GenomeConnect. More information about the Brain Gene Registry can be found on the study website - https://braingeneregistry.wustl.edu/. - |
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 14, 2023 | This sequence change replaces alanine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 302 of the KCNQ1 protein (p.Ala302Val). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This missense change has been observed in individual(s) with Jervell and Lange-Nielsen syndrome and/or long QT syndrome (PMID: 17905336, 25786344, 27917693). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 36439). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt KCNQ1 protein function with a positive predictive value of 95%. Experimental studies have shown that this missense change affects KCNQ1 function (PMID: 19808498, 25786344). For these reasons, this variant has been classified as Pathogenic. - |
Likely pathogenic, criteria provided, single submitter | clinical testing | All of Us Research Program, National Institutes of Health | Jun 26, 2023 | This missense variant replaces alanine with valine at codon 302 of the KCNQ1 protein. Computational prediction suggests that this variant may have deleterious impact on protein structure and function (internally defined REVEL score threshold >= 0.7, PMID: 27666373). This variant is found within a highly conserved pore-forming region. Rare nontruncating variants in this region have been shown to be significantly overrepresented in individuals with long QT syndrome (PMID: 32893267). A functional study has shown that this variant causes a significant reduction in channel currents (PMID: 19808498). This variant has been observed in compound heterozygous state with a known pathogenic KCNQ1 variant in an individual affected with autosomal recessive Jervell and Lange-Nielsen syndrome (PMID: 27917693), indicating that this variant contributes to disease. This variant has also been reported in heterozygous state in several individuals affected with or suspected of having Long QT syndrome (PMID: 15840476, 17905336, 22456477, 24606995), in an individual affected with sudden explained death (PMID: 15466642), Addisons disease with prolonged QTc interval (PMID: 22311567), or atrial fibrillation case (PMID: 24144883). This variant has been identified in 1/249650 chromosomes in the general population by the Genome Aggregation Database (gnomAD). Based on the available evidence, this variant is classified as Likely Pathogenic. - |
Long QT syndrome 1 Pathogenic:3
Likely pathogenic, criteria provided, single submitter | clinical testing | Human Genome Sequencing Center Clinical Lab, Baylor College of Medicine | May 01, 2018 | A heterozygous c.905C>T (p.Ala302Val) likely pathogenic variant in the KCNQ1 gene was detected in this individual. This variant has been previously described in multiple individuals with long QT syndrome and atrial fibrillation (PMID 15840476, 19716085, 17905336, 24144883, 25786344). In addition, experimental studies have shown that this variant result in altered biophysical properties of the KCNQ1 protein (PMID 19808498, 25786344). Therefore, we consider this variant to be likely pathogenic. - |
Pathogenic, criteria provided, single submitter | clinical testing | Clinical Genomics Laboratory, Washington University in St. Louis | Sep 22, 2023 | The KCNQ1 c.905C>T (p.Ala302Val) variant has been reported in several individuals affected with long QT syndrome or atrial fibrillation (Choi G et al., PMID: 15466642; Chung SK et al., PMID: 17905336; Kapplinger JD et al., PMID: 19716085; Olesen MS et al., PMID: 24144883, Steffensen AB et al., PMID: 25786344; Tester DJ et al., PMID: 15840476; Yang T et al., PMID: 19808498). At least one individual with Lange-Nielsen syndrome was compound heterozygous for this variant and a different pathogenic variant confirmed in trans (Wang C et al., PMID: 27917693). This variant has been reported in the ClinVar database as a germline pathogenic or likely pathogenic variant by seven submitters. This variant is only observed on 1/249,650 alleles in the general population (gnomAD v.2.1.1), indicating it is not a comm on variant. This variant is located in the P loop of the protein and computational predictors indicate that the variant is damaging, evidence that correlates with impact to KCNQ1 function. In support of this prediction, functional studies have shown that this variant result in altered channel kinetics and protein trafficking of the KCNQ1 protein (Steffensen AB et al., PMID: 25786344; Yang T et al., PMID: 19808498). Based on available information and the ACMG/AMP guidelines for variant interpretation (Richards S et al., PMID: 25741868), this variant is classified as pathogenic. - |
Pathogenic, criteria provided, single submitter | clinical testing | Institute of Human Genetics, University of Leipzig Medical Center | Apr 29, 2024 | Criteria applied: PS3,PS4,PM5_STR,PM1,PM2_SUP,PP3 - |
Cardiovascular phenotype Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 17, 2024 | The c.905C>T (p.A302V) alteration is located in exon 6 (coding exon 6) of the KCNQ1 gene. This alteration results from a C to T substitution at nucleotide position 905, causing the alanine (A) at amino acid position 302 to be replaced by a valine (V). Based on data from gnomAD, the T allele has an overall frequency of <0.001% (1/249650) total alleles studied. The highest observed frequency was 0.003% (1/34488) of Latino alleles. This alteration has been identified in trans with a KCNQ1 pathogenic alteration in an individual with Jervell and Lange-Nielsen syndrome, as well as in her asymptomatic father (Wang, 2017). This variant has also been detected in an individual with a history of arrhythmia events while swimming, who also harbored an additional KCNQ1 alteration, but information about phase was not provided (Choi, 2004). In addition, this alteration has been reported in individuals with lone atrial fibrillation and long QT syndrome (LQTS), as well as in LQTS clinical genetic testing cohorts; however, clinical details were limited (Tester, 2005; Chung, 2007; Kapplinger, 2009; Olesen, 2014). This amino acid position is highly conserved in available vertebrate species. Functional studies have demonstrated reduced IKs current and abnormal trafficking (Yang, 2009; Steffensen, 2015). This alteration is predicted to be deleterious by in silico analysis. Based on the available evidence, this alteration is classified as pathogenic. - |
Congenital long QT syndrome Other:1
not provided, no classification provided | literature only | Cardiovascular Biomedical Research Unit, Royal Brompton & Harefield NHS Foundation Trust | - | This variant has been reported as associated with Long QT syndrome in the following publications (PMID:15466642;PMID:15840476;PMID:17905336;PMID:19716085;PMID:19808498). This is a literature report, and does not necessarily reflect the clinical interpretation of the Imperial College / Royal Brompton Cardiovascular Genetics laboratory. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at